SCHEMBL13828427

SCHEMBL13828427

Cc1noc2c1-c1nn(C)c3ncnc(c13)N2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 2/20 0.39
▸ PIK3CD O00329 7/20 0.33
▸ PIK3CA P42336 7/20 0.33
▸ PIK3CB P42338 7/20 0.33
▸ PIK3CG P48736 7/20 0.33
▸ PRKDC P78527 7/20 0.33
▸ ABL1 P00519 6/20 0.33
▸ EGFR P00533 6/20 0.33
▸ HCK P08631 6/20 0.33
▸ SRC P12931 6/20 0.33
▸ KDR P35968 6/20 0.33
▸ MTOR P42345 6/20 0.33
▸ EPHB4 P54760 6/20 0.33
▸ PI4KB Q9UBF8 1/20 0.33
▸ NOTUM Q6P988 1/20 0.32
▸ PDE2A O00408 4/20 0.31
▸ BRD4 O60885 2/20 0.31
▸ SIGMAR1 Q99720 1/20 0.31
▸ NUDT14 O95848 1/20 0.30
▸ NUDT5 Q9UKK9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13828318 0.75 PIK3CD (0.33) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL130603 0.72 RET (0.56) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL130631 0.61 PIK3CD (0.49) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL12647324 0.61 NOTUM (0.51) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL13415398 0.59 NOTUM (0.35) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23989270 0.58 DDB1 (0.33) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL10260251 0.58 PIK3CD (0.52) RETPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL1923871 0.57 NOTUM (0.48) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23580425 0.57 NOTUM (0.51) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130503 0.56 PIK3CD (0.60) RETPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9775841-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2017-10-03 — — US disclosed
US-20120289496-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289496-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB RET 733/4885PIK3CD 47/4885PIK3CA 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback